| Date | Title | Description |
| 10.10.2013 | Ready for a growth spurt, Mobius Therapeutics lands $3M for eye surgery drug kits | “Having achieved critical regulatory, commercial, and market milestones, this investment will allow Mobius to accelerate the adoption of Mitosol, thereby improving convenience, occupational safety, consistency of patient treatment, and econ... |
| 19.11.2012 | Startup turns oft-used mitomycin C for eye surgeries into a stable, FDA-approved kit | “It’s important to differentiate the substance from the product, Mitosol,” Timm said. “Making it a product took six years and a full regulatory review.”
The last piece of Mobius’ kit for glaucoma surgery was approved by the FDA in February,... |
| 12.08.2010 | Dayton U. researcher, grad make carbon tube for glaucoma patients | In May, Lafdi got a big financial boost for his research, winning a $3 million Ohio Third Frontier grant (pdf) for the university’s Hybrid Fabrics for Multifunctional Composites project, according to the Ohio Department of Development.
Lafd... |
| 01.08.2007 | Mobius bands together $3.5M for glaucoma | Mobius Therapeutics, a St. Louis developer of glaucoma treatments, raised $3.5 million in a first funding round, VentureWire reports (subscription required). Individual investors provided the cash.
From the VentureWire story:
Based in St. L... |
| - | Startup turns oft-used mitomycin C for eye surgeries into a stable, FDA-approved kit | For years ophthalmologists have been using the drug mitomycin C off-label to modulate wound healing during eye surgeries. In glaucoma filtering surgery, it’s known to prevent post-operative scarring and reduce the risk of surgical failure. ... |
| - | Dayton U. researcher, grad make carbon tube for glaucoma patients | Who would have thought a smart nanotechnology material that keeps aircraft and wind turbine blades free from ice could help glaucoma patients?
Khalid Lafdi and Ed Timm did.
Lafdi, a research engineer at the University of Dayton Research Ins... |
| - | Ready for a growth spurt, Mobius Therapeutics lands $3M for eye surgery drug kits | Now that it’s gotten some sales traction and a fresh round of capital, Mobius Therapeutics is ready to double its sales force and ramp up education efforts for Mitosol, its first product for eye surgeons.
What Mobius has done is take the dr... |
